Does cognitive behavioral therapy using a self‐check sheet improve night‐time frequency in patients with nocturia? Results of a multicenter randomized controlled trial

Kyoda, Yuki; Okada, Manabu; Kato, Ryuichi; Matsuki, Masahiro; Ito, Naoki; Takahashi, Atsushi; Tanuma, Yasushi; Tachiki, Hitoshi; Fukuta, Fumimasa; Hashimoto, Kimio; Kobayashi, Ko; Tanaka, Toshiaki; Masumori, Naoya

doi:10.1111/iju.14489

Cited by 7 publications

(19 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 Desmopressin therapy is one of the main strategies against nocturia with NP, along with lifestyle modifications. 5,6 Cho et al have suggested that combining behavioral therapy with desmopressin increases the maximal bladder capacity and decreases the nocturnal polyuria index (NPI). 7 To prevent a unique side effect, hyponatremia, the International Continence Society suggested a practical algorithm before and after prescribing desmopressin.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study

Kyoda

Kimura

Shimizu³

et al. 2022

LUTS

View full text Add to dashboard Cite

Objectives To clarify Japanese real‐world clinical data on the use of desmopressin 25 and 50 μg orally disintegrating tablets (ODT) for male patients with nocturia and evaluate the predictive factors to improve nighttime frequency. Methods We retrospectively accumulated real‐world clinical data from 27 institutions in Japan. Male patients with two or more episodes of nocturia who received desmopressin ODT for nocturnal polyuria (NP) from 2019 through 2021 were included. The primary endpoint was the change of nighttime frequency until 3 months after desmopressin administration. The secondary endpoints were to clarify the persistence rate, adverse events, and predictive factors of decreasing nighttime frequency. Results A total of 118 patients were eligible to participate in this study. The persistence rate of desmopressin on the Kaplan‐Meier curve at week 12 was 51.3. The reason for discontinuation was mainly the occurrence of adverse events in 67 patients (56.8%), particularly hyponatremia in 7 patients (5.9%). Nighttime frequencies at baseline, ‐ 1 month and 1 ‐ 3 months after desmopressin administration were 4.1 ± 1.3, 2.9 ± 1.4 (P < .01), and 2.6 ± 1.3 (P < .01), respectively. The mean nighttime urine volume voided at baseline was significantly larger in patients whose nighttime frequency decreased by two or more times than in those with a decrease of less than two times. Conclusions Desmopressin 25 and 50 μg ODT treatments are feasible for male patients with NP in Japanese real‐world clinical practice. Patients with higher voided volumes, particularly in the nighttime, may have great benefit from desmopressin.

show abstract

Section: Introductionmentioning

confidence: 99%

“…Desmopressin therapy is one of the main strategies against nocturia with NP, along with lifestyle modifications 5,6 . Cho et al have suggested that combining behavioral therapy with desmopressin increases the maximal bladder capacity and decreases the nocturnal polyuria index (NPI) 7 .…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study

Kyoda

Kimura

Shimizu³

et al. 2022

LUTS

View full text Add to dashboard Cite

show abstract

“…Kincade et al [ 30 ] provided individualized counseling regarding self-monitoring techniques for adequate caffeine and fluid consumption and simple pelvic floor muscle training (PFMT). Kyoda et al [ 31 ] provided cognitive behavioral therapy (CBT), which included caffeine restriction and decreased water intake in the evening. Swithinbank et al [ 32 ] asked patients with urodynamic stress incontinence and idiopathic detrusor overactivity to restrict their caffeine intake for 3 weeks.…”

Section: Resultsmentioning

confidence: 99%

Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review

Park¹,

Lee²,

Kim³

et al. 2023

Int Neurourol J

View full text Add to dashboard Cite

Overactive bladder (OAB) is prevalent in men and women and negatively impacts physical and psychological health. Fluid and caffeine intake modifications, which are lifestyle modification interventions, are simple methods to manage OAB. However, studies that synthesized both interventions and found scientific evidence are scarce. This review aimed to synthesize scientific evidence on whether fluid and caffeine intake modifications are effective for OAB symptoms. PubMed, CINAHL (Cumulative Index for Nursing and Allied Health Literature), Embase, Scopus, the Cochrane Library, KoreaMed, and RISS (Research Information Sharing Service) were used to search for studies and 8 studies were included. The Cochrane risk of bias tool (RoB 2.0) and ROBINS-I (Risk Of Bias In Non-randomized Studies - of Interventions) were used to assess the quality of selected studies. Due to the heterogeneous outcome variables, a meta-analysis was not conducted. Among the 8 included, 7 studies were randomized controlled trials and one was a quasi-experimental study. Four studies assessed urgency. Caffeine reduction was statistically effective for urgency symptoms, but increasing fluid intake was not. Frequency was assessed in 5 studies, which showed decreasing caffeine and fluid intake was effective in treating the symptoms. Urinary incontinence episodes were assessed in 6 studies, and nocturia in 2. Restricting caffeine intake was effective in treating these 2 symptoms, but restricting both caffeine and fluid intake was not. Quality of life (QoL) was examined in 5 studies, and modifying fluid and caffeine intake significantly improved QoL in 2. Although there were limited studies, our review provides scientific evidence that fluid and caffeine intake modification effectively manages OAB symptoms. Further research should examine acceptability and sustainability of interventions in the long-term and enable meta-analysis.

show abstract

“…The G*power version 3.1.9.6 calculator (Franz Faul, Universität Kiel, Germany) was used for the statistical tests followed by the repeated measures analysis of variance (ANOVA) between factors, with alpha error of 0.05, power of 0.80, number of measurements 3, and effect size 0.5 (medium) [ 13 , 24 , 25 ]. Statistical analysis was performed using statistical software SPSS version 25 (IBM, Armonk, NY, USA).…”

Section: Methodsmentioning

confidence: 99%

Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome—A Randomized Clinical Trial

Jhang

Chen

et al. 2022

JCM

View full text Add to dashboard Cite

(1) Background: Introduction: Interstitial cystitis/bladder pain syndrome (IC/BPS) not only induces physiological damage but also greatly affects psychological stress. Multidisciplinary therapy has been recommended for IC/BPS treatment, but clinical trial data of combined bladder therapy and cognitive behavioral therapy (CBT) are lacking. This study evaluated CBT efficacy in patients with IC/BPS. (2) Methods: Patients with IC/BPS were randomized to the bladder monotherapy (BT) or combined CBT (CBT) group. The primary endpoint was the self-reported outcome by global response assessment (GRA). Secondary endpoints included IC symptoms and problem index, bladder pain score, Beck’s anxiety inventory (BAI), and depression inventory, and objective parameters were also compared. (3) Result: A total of 30 patients receiving BT and 30 receiving CBT therapy were enrolled. Significant improvement of the BAI at 8 (p = 0.045) and 12 weeks (p = 0.02) post-treatment was observed in the CBT group, with significantly greater GRA scores at 12 weeks (p < 0.001). Repeated measures analysis of variance showed a significant effect within the CBT group on IC/BPS patients’ self-reported treatment outcomes (p = 0.001) and anxiety severity BAI scores (p = 0.033). (4) Conclusion: A multimodal treatment of CBT combined with suitable bladder treatment more effectively improves anxiety severity and treatment outcomes in patients with IC/BPS.

show abstract

Does cognitive behavioral therapy using a self‐check sheet improve night‐time frequency in patients with nocturia? Results of a multicenter randomized controlled trial

Cited by 7 publications

References 26 publications

Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study

Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study

Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review

Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome—A Randomized Clinical Trial

Contact Info

Product

Resources

About